FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

22192002: Salicylamide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
37255011 Salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
751572014 Salicylamide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
839231000172114 salicylamide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
839241000172119 salicylamide nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salicylamide Is a Salicylate false Inferred relationship Some
Salicylamide Is a Analgesic AND antipyretic false Inferred relationship Some
Salicylamide Is a Salicylate false Inferred relationship Some
Salicylamide Is a Non-steroidal anti-inflammatory agent (substance) true Inferred relationship Some
Salicylamide Is a Substance with salicylamide structure true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Salicylamide measurement Has measured component False Salicylamide Inferred relationship Some
Salicylamide measurement Component True Salicylamide Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Salicylamide Inferred relationship Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has active ingredient False Salicylamide Inferred relationship Some
Paracetamol 250 mg and salicylamide 600 mg oral tablet Has active ingredient False Salicylamide Inferred relationship Some
Product containing paracetamol and salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Some 1
Product containing paracetamol and phenyltoloxamine citrate and salicylamide Has active ingredient False Salicylamide Inferred relationship Some
Product containing salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Some 1
Product containing caffeine and paracetamol and salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has active ingredient False Salicylamide Inferred relationship Some
Product containing benzocaine and salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Some 1
Ethenzamide Is a False Salicylamide Inferred relationship Some
Paracetamol 250 mg and salicylamide 600 mg oral tablet Has basis of strength substance (attribute) True Salicylamide Inferred relationship Some 1
Paracetamol 250 mg and salicylamide 600 mg oral tablet Has active ingredient False Salicylamide Inferred relationship Some 2
Paracetamol 250 mg and salicylamide 600 mg oral tablet Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has active ingredient False Salicylamide Inferred relationship Some 1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has active ingredient False Salicylamide Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 3
Paracetamol 250 mg and salicylamide 600 mg oral tablet Has precise active ingredient True Salicylamide Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient False Salicylamide Inferred relationship Some 3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has precise active ingredient False Salicylamide Inferred relationship Some 3
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form Has active ingredient True Salicylamide Inferred relationship Some 1
Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has precise active ingredient False Salicylamide Inferred relationship Some 2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 2
Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Some 1
Paracetamol- and salicylamide-containing product in oral dose form Has active ingredient True Salicylamide Inferred relationship Some 1
Product containing only benzocaine and salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Some 1
Caffeine and paracetamol and salicylamide only product Has active ingredient True Salicylamide Inferred relationship Some 1
Paracetamol and salicylamide only product Has active ingredient True Salicylamide Inferred relationship Some 1
Paracetamol and phenyltoloxamine and salicylamide only product Has active ingredient True Salicylamide Inferred relationship Some 1
Salicylamide only product Has active ingredient True Salicylamide Inferred relationship Some 1
Benzocaine and salicylamide only product in cutaneous dose form Has active ingredient True Salicylamide Inferred relationship Some 1
Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Some 1
Product containing only paracetamol and salicylamide in oral dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Some 1
Salicylanilide Is a False Salicylamide Inferred relationship Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has basis of strength substance (attribute) True Salicylamide Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has precise active ingredient True Salicylamide Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Salicylamide Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Salicylamide Inferred relationship Some 2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has basis of strength substance (attribute) True Salicylamide Inferred relationship Some 2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has precise active ingredient True Salicylamide Inferred relationship Some 2

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug

Back to Start